Applied BioCode (6598) — Free Cash Flow Generation Index

Latest as of September 2022: -0.89x

Applied BioCode (6598) has a Free Cash Flow Generation Index of -0.89x as of September 2022. Free cash flow of NT$-5.65 Million represents -1% of operating cash flow (NT$6.35 Million). See 6598 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

-0.89x
Free Cash Flow / Operating CF

Free Cash Flow

NT$-5.65 Million
TWD

Operating Cash Flow

NT$6.35 Million
TWD

Capital Expenditures

NT$12.00 Million
TWD

Applied BioCode Free Cash Flow Generation Index (2022–2022)

Historical FCF Generation Index trend for Applied BioCode across 1 annual periods. Explore Applied BioCode (6598) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Applied BioCode (2022–2022)

Year-by-year Free Cash Flow Generation Index for Applied BioCode. For the full company profile including market capitalisation, see 6598 market cap.

Year FCG Index Free Cash Flow (TWD) Operating CF Capital Expenditures YoY Change
2022 0.85x NT$123.73 Million NT$145.87 Million NT$22.14 Million —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).